Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest John C. Lechleiter Stories

2013-09-11 16:20:14

DEARBORN, Mich., Sept. 11, 2013 /PRNewswire/ -- Ford Motor Company (NYSE: F) announced today the election of James P. Hackett and John C. Lechleiter to the company's board of directors. Hackett's appointment is effective immediately, while Lechleiter will join the board Oct. 1. Hackett, 58, is chief executive officer of Steelcase Inc., a global leader in the office furniture industry. He was named company president and chief executive officer in December 1994, and oversees all...

2013-07-08 08:26:50

INDIANAPOLIS, July 8, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced that John C. Lechleiter, Ph.D., has returned to his duties as chairman, president, and chief executive officer. Lechleiter has been on medical leave since his scheduled surgery for a dilated aorta on May 13, 2013. Lechleiter's surgery and recovery were successful and he has been cleared by his personal physician and the company's employee health services physician to return to full-time work....

2013-05-14 08:34:28

INDIANAPOLIS, May 14, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced that John C. Lechleiter, Ph.D., chairman, president, and chief executive officer, underwent scheduled surgery for a dilated aorta on Monday, May 13, 2013. "Dr. Lechleiter's surgeons have advised us that surgery went as expected and the repair to the aorta is functioning as intended," said Kristine A. Courtney, M.D., senior director of Lilly's corporate health services. "Dr. Lechleiter is recovering...

2013-05-06 16:28:07

INDIANAPOLIS, May 6, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced that John C. Lechleiter, Ph.D., chairman, president, and chief executive officer, will undergo scheduled surgery for a dilated aorta on Monday, May 13, 2013. This condition was found during unrelated testing and has been asymptomatic. Lechleiter is expected to make a full recovery and return to his duties later this summer. In accordance with the company's bylaws, Derica W. Rice, executive vice...

2012-11-19 08:28:49

INDIANAPOLIS, Nov. 19, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will present a record-breaking gift of $12.4 million to the United Way today. As the largest gift in the company's history, the donation represents the contributions of Lilly's U.S. employees and retirees, plus a matching gift from the Lilly Foundation. Lilly Chairman, President, and Chief Executive Officer John C. Lechleiter, Ph.D., will present the check to local United Way officials today at 11 a.m. at the...

2012-06-12 14:20:43

INDIANAPOLIS, June 12, 2012 /PRNewswire/ -- Project HOPE presented John C. Lechleiter, Ph.D., chairman, president, and chief executive officer of Eli Lilly and Company (NYSE: LLY) with the inaugural Global Health Partner Award. The award recognizes Dr. Lechleiter's leadership and the longstanding partnership between Lilly and Project HOPE, which continues to help change the lives of people in need through health programs, health education, and humanitarian assistance. Dr. Lechleiter accepted...

2012-04-13 06:22:18

BOSTON, April 13, 2012 /PRNewswire-USNewswire/ -- John C. Lechleiter, Ph.D., chairman, president and CEO of Eli Lilly and Company, was elected chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) today at the trade association's annual meeting. Also elected were Celgene Corporation President, CEO, and Chairman Robert J. Hugin as chairman-elect of the PhRMA Board of Directors, and Ian C. Read, president and CEO of Pfizer, Inc., as board treasurer....

2011-11-17 07:00:00

SEATTLE, Nov. 17, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that it is providing more than $4 million in additional funding to the Infectious Disease Research Institute. The funding will allow IDRI to continue its early phase drug discovery efforts focused on identifying new and better therapies in the fight against tuberculosis, including multidrug-resistant strains known as MDR-TB. In addition, Lilly will provide more than $1 million in-kind for volunteer time...

2011-11-10 12:00:00

HONOLULU, Nov. 10, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) Chairman, President and Chief Executive Officer John C. Lechleiter, Ph.D., today said new trade agreements, effective public policies, and continued collaboration to bring innovation to patients are needed to assure improved health and economic prosperity in the Asia-Pacific region. Lechleiter's comments come as the United States hosts the Asia-Pacific Economic Cooperation (APEC) CEO Summit in Honolulu. The 21...

2011-09-13 06:00:00

INDIANAPOLIS, Sept. 13, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today a $30 million commitment over five years to fight the rising burden of non-communicable diseases in developing nations. Lilly is launching The Lilly NCD Partnership, which combines the company's unique resources with the expertise of leading global health organizations, to identify new models of patient care that increase treatment access and improve outcomes for underserved people. The...